期刊文献+

阿托伐他汀联合左卡尼汀治疗慢性心力衰竭疗效观察 预览 被引量:4

Effects of atovastatin combined with levocanitine on chronic heart failure
在线阅读 下载PDF
分享 导出
摘要 目的:探讨阿托伐他汀联合左卡尼汀对慢性心力衰竭(chronic heart failure,CHF)患者心功能及细胞因子的影响。方法:将101例慢性心力衰竭患者随机分为对照组、阿托伐他汀组和联合治疗组,对照组行常规抗心力衰竭治疗,阿托伐他汀组在常规抗心力衰竭治疗的基础上加用阿托伐他汀,联合治疗组在常规抗心力衰竭治疗的基础上加用阿托伐他汀及左卡尼汀。所有患者在治疗前及治疗6周后检测血清C反应蛋白(CRP)、血浆脑利钠肽(BNP),超声心动图检测左室射血分数(LVEF)和左室内径(LVEDD)。结果:与治疗前相比,各组治疗后CRP、BNP水平显著下降,LVEF、LVEDD明显改善(P〈0.05),阿托伐他汀组及联合治疗组CRP、BNP水平下降较对照组更为显著(均P〈0.05),LVEF、LVEDD改善较对照组明显,6min步行试验行走距离显著延长(P〈0.05)。与阿托伐他汀组相比,联合治疗组治疗后CRP、BNP水平差异及LVEF、LVEDD变化无统计学意义,但6min步行试验行走距离显著延长(P〈0.05)。结论:在常规治疗的基础上加用阿托伐他汀可进一步降低心力衰竭患者血液中CRP、BNP水平,发挥抗感染作用,同时改善患者心功能,阿托伐他汀联合左卡尼汀治疗,降低了心力衰竭患者的心肌耗氧,提高了患者的运动耐量。 Objective:To investigate the effects of atovastatin combined with levocanitine on chronic heart failure(CHF).Methods:101 patients with CHF were randomly divided into three groups,control group treated with conventional therapy,atovastatin group treated with atovastatin based on conventional therapy,and combined treatment group treated with atovastatin and levocanitine based on conventional therapy.The parameters of cardiac function,including left ventricular ejection fraction(LVEF) and left ventricular end-diastolic diameter(LVEDD),and the plasma 1evels of CRP and brain natriuretic peptide(BNP) were detected in all patients of each group before and after treatment.Results:There was significant difference in plasma levels of CRP and BNP,LVEF and LVEDD before and after treatment in all groups(P0.05).As compared with control group after treatment,the plasma levels of CRP and BNP after treatment in both atovastatin group and combined treatment group were decreased markedly(P0.05),so did LVEF,LVEDD and 6 min walk test(P0.05).There was no significant difference in changes of CRP and BNP plasma levels,LVEF and LVEDD between atovastatin group and combined group after treatment(P0.05),but 6 min walk test lengthened statistically in combined treatment group(P0.05).Conclusion:Atovastatin based on conventional therapy may play a role in anti-inflammation by lowering the plasma levels of CRP and BNP in patients with CHF,thereby improving cardiac function.Atovastatin combined with levocanitine can reduce the cardiac muscular oxygen consumption and raise the excise endurance in patients with CHF.
作者 姜喜民 景孟环 JIANG Ximin,JING Menghuan(Department of Cardiology of Huludao City Center Hospital,Liaoning Province,Huludao 125001,China)
出处 《中国当代医药》 2010年第34期 59-60,共2页 China Modern Medicine
关键词 慢性心力衰竭 阿托伐他汀 左卡尼汀 Chronic heart failure Atovastatin Levocanitine
  • 相关文献

参考文献7

二级参考文献36

  • 1Bremer J. Carnitine metabolism and function [J]. Physiol Res, 1983,63:1420-1428. 被引量:1
  • 2Regitz V, Shug AL, Fleck E. Defective myocardial metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary hypertensive and valvular heart disease[J]. Am J Cardiol,1990,65: 755-803. 被引量:1
  • 3Yusuf S, Sleight P, Pogue J, et al. Effects of angiotensin-converting enzyme, ramipil, on cardiovascular events in high 0risk patients. The Heart Outcomes Prevention Evaluation Study Investigators[J]. N Engl J Med, 2000,342(3):145-153. 被引量:1
  • 4Pott B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J]. N Engl J Med, 1999,341;709-717. 被引量:1
  • 5Anand I , Chandranshekhan Y , De Giuli F , et al. Acute and chronic effects of propionyl-carnitine on the hemodynamics, exercise capacity , and hormones in patients with congestive heart failure[J]. Cardiovasc Drugs Ther, 1988,12:291-308. 被引量:1
  • 6Ichiki T,Takeda K,Tokunou T,et al.Downregulation of angiotensin Ⅱ type 1 receptor by hydrophobic-3-hydroxy-3methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells.Arterioscler Thromb Vasc Biol,2001,21:1895-1901. 被引量:1
  • 7Bauersachs J,Galuppo P,Fraccarollo D,et al.Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme A reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction.Circulation,2001,104:982-985. 被引量:1
  • 8Patel R,Nagueh SH,Tsybouleva N,et al.Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function a transgenic rabbit model of human hypertrophic cardiomyopathy.Circulation,2001,104:317-324. 被引量:1
  • 9Hasegawa H,Yamamoto R,Takano H,et al.3-Hydroxy-3methylglutaryl coenzyme A reductase inhibitors prevent the development of cardiac hypertrophy and heart failure in rats.J Mol Cell Cardiol,2003,35:953-960. 被引量:1
  • 10Koichi T,Masaaki H,Toshikazu T.Anti-apoptotic effect of atorvastatin,a 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor,on cardiac myocytes through protein kinase C activation.Clin Exp Pharmacol Physiol,2004,31:360-367. 被引量:1

共引文献63

同被引文献27

引证文献4

二级引证文献22

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈